ALCEMI STORAGE DEVELOPMENTS 22 LIMITED

Executive Summary

ALCEMI STORAGE DEVELOPMENTS 22 LIMITED is a newly incorporated entity showing typical early-stage financial challenges with negative working capital and equity, reflecting investment and start-up costs in a capital-intensive sector. The company’s financial health currently scores a D, indicating some distress symptoms, but with appropriate liquidity support and strategic planning, it can stabilize and progress towards operational viability.

ALCEMI STORAGE DEVELOPMENTS 22 LIMITED - Analysis Report

Company Number: 14615617

Analysis Date: 2025-07-29 17:29 UTC

Financial Health Assessment: ALCEMI STORAGE DEVELOPMENTS 22 LIMITED

---

1. Financial Health Score: D

Explanation:
The company shows early-stage financial distress characterized by net current liabilities and a negative net asset base shortly after incorporation. Given it has just completed its first financial year, the financials reflect start-up challenges typical for new entities but reveal symptoms of liquidity strain and negative equity, resulting in a below-average health grade.

---

2. Key Vital Signs

Metric	Value	Interpretation
Age of Company	Less than 1 year	Start-up phase, limited operating history
Debtors (Current Assets)	£5	Minimal receivables, negligible cash inflow
Current Liabilities	£953	Short-term debts exceed assets significantly
Net Current Assets (Working Capital)	-£948	Negative working capital—symptom of liquidity stress
Total Assets Less Current Liabilities	-£948	Indicates liabilities surpass assets
Shareholders’ Funds (Equity)	-£1,048	Negative equity, indicating accumulated losses or funding gaps
Employees	0	No staff employed, possibly limited operational activity
Control	Single shareholder (Alcemi Dos Limited) with 75-100% control	Centralized control, potential for focused decision-making

---

3. Diagnosis

ALCEMI STORAGE DEVELOPMENTS 22 LIMITED is in the nascent stage of its lifecycle, with a financial profile typical of a very new company still in the investment or set-up phase. The negative working capital (-£948) and negative shareholders’ funds (-£1,048) are notable "symptoms of distress," suggesting that current liabilities outweigh assets and that the company has absorbed losses or incurred expenses not yet offset by income or capital injection.

The near-zero current assets (debtors only £5) imply an absence of liquid resources, which could hamper the company's ability to meet its short-term obligations promptly—indicative of potential cash flow issues. However, the company's directors have affirmed a going concern basis, suggesting that despite these red flags, there may be underlying financial support (e.g., from the parent company Alcemi Dos Limited) or strategic plans to stabilize finances.

The company currently has no employees, which may reduce operational overhead but also implies limited active business activity or revenue generation at this stage.

Given the company is in the production of electricity sector (SIC 35110), a capital-intensive industry, it is plausible that initial losses and negative equity are part of early development and infrastructure investment.

---

4. Recommendations

To improve financial wellness and address the symptoms identified, the company should consider the following actions:

a. Strengthen Liquidity ("Healthy Cash Flow")

• Secure additional working capital either through equity injection from the parent company or external financing to cover short-term liabilities and support operations.
• Improve cash management by accelerating debtor collections and negotiating extended payment terms with creditors.

b. Monitor and Manage Costs

• Maintain lean operations, especially if revenue generation is yet to commence, to minimize negative cash flow impact.
• Prepare a detailed budget and cash flow forecast to anticipate funding needs.

c. Develop a Clear Business Plan

• Outline milestones for moving from set-up phase to revenue generation, particularly focusing on operationalizing electricity production assets.
• Communicate this plan to stakeholders to build confidence in the company’s viability.

d. Regular Financial Review

• Conduct periodic financial health check-ups to monitor progress against plan and adjust strategies accordingly.
• Consider professional advice to explore funding options and optimize financial structure.

e. Transparency and Governance

• Maintain accurate and timely filings and disclosures to preserve corporate compliance and good standing.
• Ensure experienced directors remain active in governance to guide through the startup phase.

---